Clinical trial
A Study Of Nasopharyngeal Carcinoma (NPC) Treated With Celecoxib And ZD1839
NCT00212108 · National University Hospital, Singapore, Other · Completed
Key facts
| NCT number | NCT00212108 |
|---|---|
| Title | A Study Of Nasopharyngeal Carcinoma (NPC) Treated With Celecoxib And ZD1839 |
| Official title | A Study Of Nasopharyngeal Carcinoma (NPC) Treated With Celecoxib And ZD1839 |
| Lead sponsor | National University Hospital, Singapore, Other |
| Collaborators | National Healthcare Group, Singapore |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Nasopharyngeal Carcinoma |
| Intervention type | Drug |
| Interventions | celecoxib, gefitinib |
| Enrollment | 22 |
| Start date | Nov 1, 2003 |
| Primary completion | Mar 1, 2007 |
| Completion | Jan 1, 2009 |
| First posted | Sep 21, 2005 |
| Last update posted | Apr 2, 2012 |
| Countries | Singapore |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: